This Journal of Clinical Investigation review describes how glucagon-like peptide-1 (GLP-1)–based medicines reduce systemic and tissue inflammation through both weight-dependent and weight-independent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback